Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024)
Debasis Das, Lingzhi Xie, Jian Hong
Abstract
Prospects of novel fourth-generation EGFR-TKIs overcoming C797S-mediated resistance in non-small cell lung cancer.
Topics & Concepts
Lung cancerCancer researchTyrosine kinaseMutationMedicineProtein-Tyrosine KinasesKinaseCancerOncologyBiologyInternal medicineGeneticsGeneReceptorLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment